Oncological Pathology at Home: One Year of Experience

Authors

  • Paula Mariano Unidade de Hospitalização Domiciliária, Serviço de Medicina Interna, Hospital Amato Lusitano, Castelo Branco, Portugal https://orcid.org/0000-0001-7051-9770
  • Soraia Silva Unidade de Hospitalização Domiciliária, Serviço de Medicina Interna, Hospital Amato Lusitano, Castelo Branco, Portugal https://orcid.org/0000-0002-6315-060X
  • Maria Eufémia Calmeiro Unidade de Hospitalização Domiciliária, Serviço de Medicina Interna, Hospital Amato Lusitano, Castelo Branco, Portugal https://orcid.org/0000-0002-7209-6481
  • Isabel Antunes Unidade de Hospitalização Domiciliária, Serviço de Medicina Interna, Hospital Amato Lusitano, Castelo Branco, Portugal https://orcid.org/0000-0002-0172-8453
  • Maria Eugénia André Unidade de Hospitalização Domiciliária, Serviço de Medicina Interna, Hospital Amato Lusitano, Castelo Branco, Portugal

DOI:

https://doi.org/10.24950/O/142/20/4/2020

Keywords:

Fever, Home Care Services, Hospital-Based, Neoplasms, Neutropenia

Abstract

Introduction: Neoplasia is considered the second disease with the highest morbidity and mortality. Hospital-level care is often unavoidable. The objective of Home Hospitalization (HH) is to minimize hospital complications and provide greater satisfaction to the patient and family/caregiver.

Material and Methods: This article reports one year of HH experience at the Unidade Local de Saúde of Castelo Branco with regard to patients with oncological pathology.

Results/Discussion: In the first year of HH, 99 patients were admitted, 22.2% (n = 22) of whom had oncological pathology. Sixty four percent were male and the average age was 65.9 years old (±12.8). The average hospital stay was 6.8 days (±3.4). Seventy seven percent had active cancer disease. The main existing neoplasias were: 31.8% lung, 22.7% hematological, 18.1% prostate and 13.6% breast. Of these, 58.8% were under chemotherapy and 17.6% had undergone recent surgery or radiation therapy. The main comorbidities found in these patients were: hypertension, type 2 diabetes mellitus, obstructive sleep apnea syndrome and chronic pain. The main reasons for hospitalization were: febrile neutropenia (36.3%), respiratory infection (27.2%) and pain control (13.6%). One patient died, one was transferred to hospital and three readmissions. Ninety days after discharge, 63.6% did not return to the hospital.

Conclusion: Hospitalization in patients with neoplasia is very common. These are at increased risk of suffering from in-hospital infections, which increases mortality. The HH is advantageous because it reduces complications and provides a better quality of life for patients, given that they are undergoing qualified treatment in their own home.

Downloads

Download data is not yet available.

References

Handley NR, Bekelman JE. The Oncology Hospital at Home. J Clin Oncol. 2019;37:448-52. doi: 10.1200/JCO.18.01167.

Direção Geral da Saúde. Hospitalização Domiciliária em idade adulta: Norma nº 020/2018 de 20/12/2018. Lisboa: DGS; 2018.

Cunha V, Escarigo MC, Correia J, Nortadas R, Azevedo PC, Beirão P, et al; Hospitalização Domiciliária: Balanço de um Ano da Primeira Unidade Portuguesa; Rev Soc Port Med Intern. VOL.24 | N.º 4 | OUT/DEZ 2017

Guimaraes MD, Bitencourt AG, Marchiori E, Chojniak R, Gross JL, Kundra V. Imaging acute complications in cancer patients: what should be evaluated in the emergency setting? Cancer Imaging. 2014;14:18. doi: 10.1186/1470-7330-14-18.

Cotta RM, Morales Suárez-Varela M, Cotta Filho JS, Llopis González A, Días Ricós JA, Real ER. La hospitalización domiciliaria ante los cambios demográficos y nuevos retos de salud. Rev Panam Salud Publica. 2002;11:253-61. 6.

Atalaia G, Vasconcelos P, Bragança N. Neutropenia febril. Rev Clin Hosp Prof Dr Fernando Fonseca. 2015; 3: 13-9.

Talcott JA, Finberg R, Mayer RJ, Goldman L. The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation. Arch Intern Med. 1988148:2561-8.

Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R. The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol. 2000;18:3038-51.

Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, et al. Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update. J Clin Oncol. 2018;36:1443-53. doi: 10.1200/JCO.2017.77.6211.

Hendricks AM, Loggers ET, Talcott JA. Costs of home versus inpatient treatment for fever and neutropenia: analysis of a multicenter randomized trial. J Clin Oncol. 20110;29:3984-9. doi: 10.1200/JCO.2011.35.1247. Erratum in: J Clin Oncol. 2011;29:4847.

Published

2021-09-23

How to Cite

1.
Mariano P, Silva S, Calmeiro ME, Antunes I, André ME. Oncological Pathology at Home: One Year of Experience. RPMI [Internet]. 2021 Sep. 23 [cited 2024 Nov. 23];27(4):302-6. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/99

Issue

Section

Original Articles

Most read articles by the same author(s)